[ Price : $8.95]
Federal Register notice: FDA determines for patent extension-related purposes the regulatory review period for Regeneron Pharmaceu...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension-related purposes the regulatory review period for Provepharms Provayb...[ Price : $8.95]
AdvaMed and other industry groups comment on FDAs recent draft guidance on The Special 510(k) Program, suggesting that the documen...[ Price : $8.95]
FDA approves a Medifocus PMA supplement for new labeling for its Prolieve Transurethral ThermoDilatation Therapy based on the resu...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension entitled: Oversight of Clinical Investigations:...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Blood Glucose Monitoring Test Systems for Prescription Poin...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Self-Monitoring Blood Glucose Test Systems for Over-the-Cou...[ Price : $8.95]
Federal Register notice: FDA announces a 1/16 Bone, Reproductive and Urologic Drugs Advisory Committee meeting to discuss an Amgen...